Systemic Delivery of mLIGHT-Armed Myxoma Virus Is Therapeutic for Later-Stage Syngeneic Murine Lung Metastatic Osteosarcoma is a research paper published in Cancers (2022). On theSindex it has a DataRank of 0. It has been cited 11 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 5R21CA249517-02
Cancer therapy with a combination of oncolytic bacteria and virus to enhance targeted cell killing and anti-tumor immune responses
National Institutes of Health
Grant: 5R01AI080607-04
Studies in Poxvirus Host Range Genes and Tropism
NIAID NIH HHS
Grant: R01 AI080607
NCI NIH HHS
Grant: R21 CA249517
FWCI
1.52
Citation Percentile
0.8%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals